Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

CILOSTAZOL Drug Profile

« Back to Dashboard

Which patents cover Cilostazol, and what generic Cilostazol alternatives are available?

Cilostazol is a drug marketed by Breckenridge Pharm, Frontida Biopharm, Sandoz, Mylan Pharms Inc, Ivax Sub Teva Pharms, Biokey, Corepharma, Mylan, West-ward Pharms Int, Teva, Actavis Elizabeth, Apotex Inc, and Pliva Hrvatska Doo. and is included in sixteen NDAs.

The generic ingredient in CILOSTAZOL is cilostazol. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cilostazol profile page.

Summary for Tradename: CILOSTAZOL

Patents:0
Applicants:13
NDAs:16
Suppliers / Packagers: see list20
Bulk Api Vendors: see list80
Clinical Trials: see list29
Patent Applications: see list3,791
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CILOSTAZOL at DailyMed

Pharmacology for Tradename: CILOSTAZOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Breckenridge Pharm
CILOSTAZOL
cilostazol
TABLET;ORAL077708-001Sep 28, 2009ABRXNoNo► Subscribe► Subscribe
Actavis Elizabeth
CILOSTAZOL
cilostazol
TABLET;ORAL077028-002Nov 26, 2004DISCNNoNo► Subscribe► Subscribe
Pliva Hrvatska Doo
CILOSTAZOL
cilostazol
TABLET;ORAL077898-002Oct 29, 2007DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
CILOSTAZOL
cilostazol
TABLET;ORAL077019-002Nov 23, 2004DISCNNoNo► Subscribe► Subscribe
Frontida Biopharm
CILOSTAZOL
cilostazol
TABLET;ORAL077208-001Mar 29, 2006DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot